Mirjana Mačvanin

806 total citations
29 papers, 520 citations indexed

About

Mirjana Mačvanin is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Mirjana Mačvanin has authored 29 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Cancer Research. Recurrent topics in Mirjana Mačvanin's work include Cancer-related molecular mechanisms research (6 papers), Bacterial Genetics and Biotechnology (5 papers) and RNA and protein synthesis mechanisms (5 papers). Mirjana Mačvanin is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Bacterial Genetics and Biotechnology (5 papers) and RNA and protein synthesis mechanisms (5 papers). Mirjana Mačvanin collaborates with scholars based in Serbia, United States and Sweden. Mirjana Mačvanin's co-authors include Esma R. Isenović, Sankar Adhya, Diarmaid Hughes, Zoran Gluvić, Xin Gao, Magbubah Essack, Božidarka Zarić, Jelena Radovanović, Sonja Zafirović and Victor B. Zhurkin and has published in prestigious journals such as Journal of Bacteriology, Antimicrobial Agents and Chemotherapy and Molecular Microbiology.

In The Last Decade

Mirjana Mačvanin

28 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirjana Mačvanin Serbia 14 268 145 63 62 58 29 520
Brian O. Ingram United States 13 303 1.1× 88 0.6× 31 0.5× 38 0.6× 57 1.0× 21 654
Hind Ray France 10 249 0.9× 63 0.4× 39 0.6× 19 0.3× 18 0.3× 10 512
Mohsen Masoodi Iran 16 155 0.6× 68 0.5× 25 0.4× 14 0.2× 45 0.8× 58 669
M Yamazaki Japan 12 244 0.9× 37 0.3× 30 0.5× 42 0.7× 23 0.4× 25 567
S. M. A. Abidi India 16 92 0.3× 36 0.2× 51 0.8× 170 2.7× 24 0.4× 58 693
Junhao Chen China 9 244 0.9× 37 0.3× 15 0.2× 12 0.2× 52 0.9× 23 396
Ying Lei United States 9 227 0.8× 58 0.4× 13 0.2× 38 0.6× 210 3.6× 16 605
Dongguo Wang China 14 192 0.7× 36 0.2× 12 0.2× 23 0.4× 117 2.0× 46 502
Changgeng Xu China 16 248 0.9× 22 0.2× 19 0.3× 11 0.2× 27 0.5× 26 537

Countries citing papers authored by Mirjana Mačvanin

Since Specialization
Citations

This map shows the geographic impact of Mirjana Mačvanin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjana Mačvanin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjana Mačvanin more than expected).

Fields of papers citing papers by Mirjana Mačvanin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjana Mačvanin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjana Mačvanin. The network helps show where Mirjana Mačvanin may publish in the future.

Co-authorship network of co-authors of Mirjana Mačvanin

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjana Mačvanin. A scholar is included among the top collaborators of Mirjana Mačvanin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjana Mačvanin. Mirjana Mačvanin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mačvanin, Mirjana, Zoran Gluvić, Jelena Radovanović, et al.. (2023). New insights on the cardiovascular effects of IGF-1. Frontiers in Endocrinology. 14. 1142644–1142644. 45 indexed citations
2.
Mačvanin, Mirjana, Zoran Gluvić, Manfredi Rizzo, et al.. (2023). SGLT-2 Inhibitors: The Next-generation Treatment for Type 2Diabetes Mellitus. Current Medicinal Chemistry. 31(30). 4781–4806. 6 indexed citations
3.
Mačvanin, Mirjana, Zoran Gluvić, Aleksandra Klisić, et al.. (2023). The Link between miRNAs and PCKS9 in Atherosclerosis. Current Medicinal Chemistry. 31(42). 6926–6956. 7 indexed citations
4.
Mačvanin, Mirjana, Sonja Zafirović, Milan Obradović, et al.. (2023). Nitric oxide, thyroglobulin, and calcitonin: unraveling the nature of thyroid nodules. Frontiers in Endocrinology. 14. 1241223–1241223.
5.
Mačvanin, Mirjana, Zoran Gluvić, Vladan Bajić, & Esma R. Isenović. (2023). Novel insights regarding the role of noncoding RNAs in diabetes. World Journal of Diabetes. 14(7). 958–976. 5 indexed citations
6.
Bajić, Vladan, Mirjana Mačvanin, Esma R. Isenović, et al.. (2023). Type 2 Diabetes Mellitus and its comorbidity, Alzheimer’s disease: Identifying critical microRNA using machine learning. Frontiers in Endocrinology. 13. 1084656–1084656. 17 indexed citations
7.
Mačvanin, Mirjana, Zoran Gluvić, Božidarka Zarić, et al.. (2023). New biomarkers: prospect for diagnosis and monitoring of thyroid disease. Frontiers in Endocrinology. 14. 1218320–1218320. 11 indexed citations
8.
Mačvanin, Mirjana, Zoran Gluvić, Jelena Radovanović, et al.. (2023). Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs. Frontiers in Endocrinology. 14. 1124613–1124613. 22 indexed citations
9.
Mačvanin, Mirjana, Zoran Gluvić, Sonja Zafirović, et al.. (2023). The protective role of nutritional antioxidants against oxidative stress in thyroid disorders. Frontiers in Endocrinology. 13. 1092837–1092837. 37 indexed citations
10.
Mačvanin, Mirjana, Milan Obradović, Zoran Gluvić, et al.. (2023). Impact of treatment modalities on quality of life and depression in type 2 diabetes.. PubMed. 27(11). 4980–4989. 1 indexed citations
11.
Mačvanin, Mirjana, Milan Obradović, Sonja Zafirović, Julijana Stanimirović, & Esma R. Isenović. (2022). The Role of miRNAs in Metabolic Diseases. Current Medicinal Chemistry. 30(17). 1922–1944. 28 indexed citations
12.
Zarić, Božidarka, Mirjana Mačvanin, & Esma R. Isenović. (2022). Free radicals: Relationship to Human Diseases and Potential Therapeutic applications. The International Journal of Biochemistry & Cell Biology. 154. 106346–106346. 48 indexed citations
13.
Nikolić‐Kokić, Aleksandra, Snežana Spasić, Mirjana Mačvanin, et al.. (2019). Opposite clozapine and ziprasidone effects on the reactivity of plasma albumin SH-group are the consequence of their different binding properties dependent on protein fatty acids content. Chemico-Biological Interactions. 311. 108787–108787. 2 indexed citations
14.
Mačvanin, Mirjana, Rotem Edgar, Feng Cui, et al.. (2012). Noncoding RNAs Binding to the Nucleoid Protein HU in Escherichia coli. Journal of Bacteriology. 194(22). 6046–6055. 43 indexed citations
15.
Mačvanin, Mirjana & Sankar Adhya. (2012). Architectural organization in E. coli nucleoid. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1819(7). 830–835. 61 indexed citations
16.
Mačvanin, Mirjana & Diarmaid Hughes. (2010). Assays of Sensitivity of Antibiotic-Resistant Bacteria to Hydrogen Peroxide and Measurement of Catalase Activity. Methods in molecular biology. 642. 95–103. 10 indexed citations
17.
Mačvanin, Mirjana & Diarmaid Hughes. (2005). Hyper-susceptibility of a fusidic acid-resistant mutant ofSalmonellato different classes of antibiotics. FEMS Microbiology Letters. 247(2). 215–220. 24 indexed citations
18.
19.
Mačvanin, Mirjana, Urban Johanson, Måns Ehrenberg, & Diarmaid Hughes. (2000). Fusidic acid‐resistant EF‐G perturbs the accumulation of ppGpp. Molecular Microbiology. 37(1). 98–107. 37 indexed citations
20.
Mačvanin, Mirjana, et al.. (1998). Adrenalectomy and dexamethasone treatment alter the patterns of basal and acute phase response-induced expression of acute phase protein genes in rat liver. The Journal of Steroid Biochemistry and Molecular Biology. 66(5-6). 347–353. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian O. Ingram Breakdown of academic impact, for papers by Hind Ray Breakdown of academic impact, for papers by Mohsen Masoodi Breakdown of academic impact, for papers by M Yamazaki Breakdown of academic impact, for papers by S. M. A. Abidi Breakdown of academic impact, for papers by Junhao Chen Breakdown of academic impact, for papers by Ying Lei Breakdown of academic impact, for papers by Dongguo Wang Breakdown of academic impact, for papers by Changgeng Xu
Rankless by CCL
2026